Occurrence and significance of epithelial-mesenchymal transition in breast cancer

被引:36
|
作者
Roxanis, Ioannis [1 ]
机构
[1] Oxford Univ Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England
关键词
RECEPTOR TYROSINE KINASES; E-CADHERIN EXPRESSION; ACTIVATED AKT KINASE; GROWTH-FACTOR-BETA; TGF-BETA; TUMOR PROGRESSION; BASAL-LIKE; DUCTAL CARCINOMA; COLORECTAL CANCERS; SIGNALING PATHWAYS;
D O I
10.1136/jclinpath-2012-201348
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
By contrast with developmental epithelial-mesenchymal transition (EMT), where epithelial characteristics undergo transformation to a mesenchymal-like phenotype in a coordinated fashion, oncogenic EMT occurs in the context of unpredictable genetic changes present in the tumour cells, as well as an abnormal tumour microenvironment. Therefore, a partial form of EMT has been proposed as variably participating in the establishment of invasive phenotype in different types of breast carcinoma, in keeping with their morphological and phenotypical diversity. A complex network of signalling pathways and transcription factors appears responding to various growth factors and cytokines released by stromal and neoplastic elements, endowing the system with abundant regulatory opportunities. The process of EMT is largely elusive in histopathological preparations, prompting doubts regarding its significance in tumour progression. This might be related to the presumed focal occurrence of EMT in the majority of tumours. Detailed topological studies might facilitate understanding of the orchestration of events taking place in vivo. Even more importantly, clinical correlations can be endeavoured and, in parallel with advancement in molecular pathology, a contribution to taxonomy refinement can be envisaged.
引用
收藏
页码:517 / 521
页数:5
相关论文
共 50 条
  • [41] Links between cancer stem cells and epithelial-mesenchymal transition
    Wang, Sha-sha
    Jiang, Jian
    Liang, Xin-hua
    Tang, Ya-ling
    ONCOTARGETS AND THERAPY, 2015, 8 : 2973 - 2980
  • [42] Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoids
    Bar-Hai, Neta
    Ben-Yishay, Rakefet
    Arbili-Yarhi, Sheli
    Herman, Naama
    Avidan-Noy, Vered
    Menes, Tehillah
    Mansour, Aiham
    Awwad, Fahim
    Balint-Lahat, Nora
    Goldinger, Gil
    Hout-Siloni, Goni
    Adileh, Mohammad
    Berger, Raanan
    Ishay-Ronen, Dana
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [43] Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer
    Huang, Ruby Yun-Ju
    Chung, Vin Yee
    Thiery, Jean Paul
    CURRENT DRUG TARGETS, 2012, 13 (13) : 1649 - 1653
  • [44] New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
    Dongre, Anushka
    Weinberg, Robert A.
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2019, 20 (02) : 69 - 84
  • [45] Role of epithelial-mesenchymal transition in gastric cancer initiation and progression
    Peng, Zhao
    Wang, Chen-Xiao
    Fang, Er-Hu
    Wang, Guo-Bin
    Tong, Qiang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (18) : 5403 - 5410
  • [46] Molecular mechanisms of epithelial-mesenchymal transition
    Lamouille, Samy
    Xu, Jian
    Derynck, Rik
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (03) : 178 - 196
  • [47] Epithelial-mesenchymal transition in hepatocellular carcinoma
    van Zijl, Franziska
    Zulehner, Gudrun
    Petz, Michaela
    Schneller, Doris
    Kornauth, Christoph
    Hau, Mara
    Machat, Georg
    Grubinger, Markus
    Huber, Heidemarie
    Mikulits, Wolfgang
    FUTURE ONCOLOGY, 2009, 5 (08) : 1169 - +
  • [48] The miRNAs and Epithelial-Mesenchymal Transition in Cancers
    Lin, Ching-Wen
    Kao, Shih-Han
    Yang, Pan-Chyr
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (33) : 5309 - 5318
  • [49] Dynamic Transcription Factor Networks in Epithelial-Mesenchymal Transition in Breast Cancer Models
    Siletz, Anaar
    Schnabel, Michael
    Kniazeva, Ekaterina
    Schumacher, Andrew J.
    Shin, Seungjin
    Jeruss, Jacqueline S.
    Shea, Lonnie D.
    PLOS ONE, 2013, 8 (04):
  • [50] Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer
    Haque, Mazharul
    Shyanti, Ritis K.
    Mishra, Manoj K.
    FRONTIERS IN ONCOLOGY, 2024, 14